JC

Jeffrey Cummings

Scientific Advisor at Acumen Pharmaceuticals

Jeffrey Cummings, MD, ScD is Director Emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health, Vice Chair of the department of brain health at the University of Nevada, Las Vegas, Professor of Medicine (Neurology) at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and a Principal Investigator/Director of the NIH/NIGMS-funded Center for Neurodegeneration and Translational Neuroscience.

Dr. Cummings is a world-renowned Alzheimer’s researcher and leader of clinical trials. He has been recognized for his research and leadership contributions in the field of Alzheimer’s disease through the Henderson Award of the American Geriatrics Society (2006), the Ronald and Nancy Reagan Research Award of the national Alzheimer’s Association (2008), and the Lifetime Achievement Award of the Society for Behavioral and Cognitive Neurology (2017). In 2010, he was honored by the American Association of Geriatric Psychiatry with their Distinguished Scientist Award. In 2018, he was honored with the Leadership and Achievement Award by the International Society of CNS Drug Development, and he received the Bengt Winblad Lifetime Achievement Award from the national Alzheimer’s Association.

Dr. Cummings’ interests embrace clinical trials, developing new therapies for brain diseases, and the interface of neuroscience and society, and he has authored or edited 43 books and published over 725 peer-reviewed papers.

Timeline

  • Scientific Advisor

    Current role